Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

9.5K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
9.5K
Selectins01:25

Selectins

4.1K
Cell adhesion is  an essential aspect of multicellularity. While stable cell interactions usually occur between cells of the same type, transient cell interactions occur between cells of different tissue types, such as between neutrophils and endothelial cells. Selectins are one class of cell adhesion molecules (CAMs) that bind carbohydrate ligands to form transient cell adhesion. They are rod-like proteins with a long extracellular part of variable length ending with the lectin domain,...
4.1K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Analgesia and Pain Management01:25

Analgesia and Pain Management

1.4K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of antibody non-specificity using protein language models and biophysical parameters.

mAbs·2026
Same author

AutoPocket2CREST: Automating Binding Pocket Extraction for the CREST Conformer Generation Pipeline.

Journal of chemical information and modeling·2026
Same author

A Once-Weekly C-Type Natriuretic Peptide for Treatment of Heart Failure with Preserved Ejection Fraction.

Journal of medicinal chemistry·2025
Same author

GRADE and X-GRADE: Unveiling Novel Protein-Ligand Interaction Fingerprints Based on GRAIL Scores.

Journal of chemical information and modeling·2025
Same author

Molecular Representations in Machine-Learning-Based Prediction of PK Parameters for Insulin Analogs.

ACS omega·2023
Same author

Development of Cagrilintide, a Long-Acting Amylin Analogue.

Journal of medicinal chemistry·2021

Related Experiment Video

Updated: Jan 7, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

13.1K

From Cancer to Pain Target by Automated Selectivity Inversion of a Clinical Candidate.

Samo Turk1, Benjamin Merget1, Sameh Eid1

  • 1BioMed X Innovation Center , Im Neuenheimer Feld 515 , 69120 Heidelberg , Germany.

Journal of Medicinal Chemistry
|May 11, 2018
PubMed
Summary
This summary is machine-generated.

Researchers optimized tozasertib to target the pain receptor TrkA, achieving 10,000-fold improved selectivity over its original cancer target AurA. This advance in computer-aided drug design offers a powerful new approach for developing selective kinase inhibitors.

More Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.0K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

9.2K

Related Experiment Videos

Last Updated: Jan 7, 2026

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery
09:38

Determining Pain Detection and Tolerance Thresholds Using an Integrated, Multi-Modal Pain Task Battery

Published on: April 14, 2016

13.1K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

9.0K
Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging
10:47

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

9.2K

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Drug Discovery

Background:

  • Inhibitor design requires eliminating off-target binding, especially for conserved protein families like kinases.
  • Compounds in clinical trials offer opportunities to leverage secondary binding events for drug design.
  • Shifting selectivity from a cancer target (AurA) to a pain target (TrkA) presents a significant challenge.

Purpose of the Study:

  • To redesign tozasertib, originally an Aurora A kinase (AurA) inhibitor, to selectively target Tropomyosin receptor kinase A (TrkA) for pain management.
  • To develop a computational and machine learning-driven approach for automated drug design and selection.
  • To demonstrate the feasibility of achieving high selectivity and potency in a single round of in silico optimization.

Main Methods:

  • Identification of selectivity-determining features by analyzing interaction grids of kinase binding pockets.
  • Creation of a focused compound library using computational chemistry and machine learning-based multiobjective selection.
  • Synthesis and experimental validation of high-ranking compounds against target and off-target kinases.
  • Automated in silico optimization using advanced computer-aided drug design (CADD) techniques.

Main Results:

  • A top-ranked compound exhibited 10,000-fold improved selectivity for TrkA over AurA.
  • The optimized compound demonstrated nanomolar cellular activity.
  • High selectivity was confirmed across a broad kinase panel.
  • The study successfully achieved significant optimization in a single automated cycle.

Conclusions:

  • Computer-aided drug design advancements can automate and accelerate the optimization of selective kinase inhibitors.
  • The developed methodology effectively shifts inhibitor selectivity towards desired therapeutic targets.
  • This approach holds significant promise for developing novel therapeutics with improved safety and efficacy profiles.